We are active participants in the Image Gently and Image Wisely campaigns to
reduce radiation dose.
They found that using the VASH collimator with an existing breast molecular imaging system, they could get six times better contrast of tumors in the breast, which could potentially
reduce the radiation dose to the patient by half from the current levels, while maintaining the same or better image quality.
«The ability to accelerate image acquisition and
reduce radiation dose opens up new horizons, particularly in life sciences and soft matter research, by electron tomography,» says Prof. Rafal Dunin - Borkowski.
Adding this variable angle slant hole collimator to an existing breast molecular imaging system allows the system to get six times better contrast of cancer lesions in the breast, providing the same or better image quality while also potentially
reducing the radiation dose to the patient by half.
Not exact matches
«In an earlier phase I clinical study, our group has shown that increasing the
dose of
radiation delivered daily with high precision and using image guidance may offset the need for chemotherapy in improving survival, and it may also improve quality of life measures by
reducing treatment periods in half.
The patent - pending technology, which uses detectors at the heart of the Large Hadron Collider at CERN alongside world - first
radiation - hard CMOS imagers, will
reduce dose uncertainties from several centimetres to just a few millimetres.
Now, researchers are hoping to improve this imaging technique, known as molecular breast imaging or breast specific gamma imaging, with better image quality and precise location (depth information) within the breast, while
reducing the amount of
radiation dose to the patient for these procedures.
Orthopaedic surgery and radiology collaborators have also implemented intraoperative use of low -
dose protocols on fluoroscopy machines, which
reduces radiation exposure to both patients as well as physicians and staff in the operating room.
«These studies suggest the potential for dramatically
reducing the
dose of chemotherapy or
radiation and thereby
reducing the side effects of standard chemotherapy by enhancing the targeting of cancer therapies using HIV receptor blocking drugs.»
«In theory, it could lower the
dose for cure for many cancers, which is great progress because any amount we can
reduce the
radiation means fewer complications,» said study co-author Ralph Weichselbaum, the Daniel K. Ludwig Distinguished Service Professor and chair of the Department of
Radiation and Cellular Oncology, «and we also hope that the potential activation of the immune system may help us treat tumors that we just can't reach today.»
The team of researchers harvested hematopoietic stem cells from three macaques prior to SHIV infection of all six animals in the study, treated the animals with anti-retroviral therapy (ART) to
reduce viral load and mimic the situation in human HIV - infected patients who are treated with ART, and then exposed the three monkeys from which they had collected hematopoietic stem cells to a high
dose of
radiation.
With continuous chemotherapy,
radiation and medication of high
dose, the immune system of a cancer patient starts to weaken with
reduced formation of leukocytes.
In this case,
reduced doses of
radiation therapy called palliative
radiation therapy may be used to shrink the tumor enough to relieve signs of pain or discomfort for a period of time.
The Low
Dose Radiation Research Act of 2015 directs the two organisations to carry out a research program «to enhance the scientific understanding of and reduce uncertainties associated with the effects of exposure to low dose radiation in order to inform improved risk management methods.&ra
Dose Radiation Research Act of 2015 directs the two organisations to carry out a research program «to enhance the scientific understanding of and
reduce uncertainties associated with the effects of exposure to low
dose radiation in order to inform improved risk management methods.&ra
dose radiation in order to inform improved risk management methods.»